TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Plus Therapeutics ( (PSTV) ) has provided an announcement.
On November 17, 2025, Plus Therapeutics announced it received an additional 180-day extension from Nasdaq to comply with the $1.00 minimum bid price requirement, extending the deadline to May 11, 2026. The extension allows Plus Therapeutics to continue trading on the Nasdaq Capital Market under the symbol ‘PSTV’ without immediate risk of delisting. The company is considering options, including a reverse stock split, to meet compliance, but there is no assurance of success. Failure to comply could result in delisting, which can be appealed.
The most recent analyst rating on (PSTV) stock is a Buy with a $2.00 price target. To see the full list of analyst forecasts on Plus Therapeutics stock, see the PSTV Stock Forecast page.
Spark’s Take on PSTV Stock
According to Spark, TipRanks’ AI Analyst, PSTV is a Neutral.
The overall stock score is heavily influenced by the company’s poor financial performance, characterized by consistent losses and negative equity. Technical analysis suggests a bearish trend, while valuation metrics are unattractive due to negative earnings. These factors collectively indicate significant risks for investors.
To see Spark’s full report on PSTV stock, click here.
More about Plus Therapeutics
Plus Therapeutics, Inc., headquartered in Houston, Texas, is a clinical-stage pharmaceutical company focused on developing targeted radiotherapeutics for central nervous system cancers. The company employs advanced platform technologies, including image-guided local beta radiation and targeted drug delivery, to enhance clinical outcomes. Plus Therapeutics is advancing a pipeline with lead programs in leptomeningeal metastases and recurrent glioblastoma, supported by a strategic supply chain for development and potential commercialization.
Average Trading Volume: 18,594,305
Technical Sentiment Signal: Strong Sell
Current Market Cap: $70.29M
Find detailed analytics on PSTV stock on TipRanks’ Stock Analysis page.